Preoperative CEA&CA19-9&CA125 model vs preoperative CEA model | ||||
 | Percentage of individuals for whom the preoperative CEA&CA19-9&CA125 model estimates a higher risk than the preoperative CEA model | Percentage of individuals for whom the preoperative CEA&CA19-9&CA125 model estimates a lower risk than the preoperative CEA model | Overall net reclassification improvement (95% confidence interval) | P for net reclassification improvement |
 24 months | ||||
  Events | 64.29% | 35.71% | 34.05% (3.29%, 64.81%) | 0.015 |
  Non-events | 47.26% | 52.74% | ||
 36 months | ||||
  Events | 59.57% | 40.43% | 33.53% (12.28%, 54.78%) | 0.001 |
  Non-events | 42.81% | 57.19% | ||
 48 months | ||||
  Events | 60.47% | 39.53% | 36.04% (17.18%, 54.90%) | < 0.001 |
  Non-events | 42.45% | 57.55% | ||
 60 months | ||||
  Events | 57.62% | 42.38% | 21.47% (2.95%, 39.99%) | 0.012 |
  Non-events | 46.88% | 53.12% | ||
Longitudinal CEA&CA19-9&CA125 model vs preoperative CEA&CA19-9&CA125 model | ||||
 | Percentage of individuals for whom the longitudinal CEA&CA19-9&CA125 model estimates a higher risk than the preoperative CEA&CA19-9&CA125 model | Percentage of individuals for whom the longitudinal CEA&CA19-9&CA125 model estimates a lower risk than the preoperative CEA&CA19-9&CA125 model | Overall net reclassification improvement (95% confidence interval) | P for net reclassification improvement |
 24 months | ||||
  Events | 73.81% | 26.19% | 64.87% (34.11%, 95.63%) | < 0.001 |
  Non-events | 41.37% | 58.63% | ||
 36 months | ||||
  Events | 62.77% | 37.23% | 40.81% (19.56%, 62.06%) | < 0.001 |
  Non-events | 42.36% | 57.64% | ||
 48 months | ||||
  Events | 60.47% | 39.53% | 30.30% (11.44%, 49.16%) | 0.001 |
  Non-events | 45.32% | 54.68% | ||
 60 months | ||||
  Events | 56.95% | 43.05% | 24.76% (6.24%, 43.28%) | 0.004 |
  Non-events | 44.57% | 55.43% |